Antiagregation and anticoagulation, relationship with upper gastrointestinal bleeding

Revista Espanola de Enfermedades Digestivas

Volumn 103, Issue 7, 2011, Pages 360-365

  Wikman Jorgensen, Philip ^a   López Calleja, Eva ^a   Safont Gasó, Pablo ^a   Matarranz del Amo, Mariano ^a   Andrés Navarro, Raquel ^a   Merino Sánchez, Jaime ^a  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

Author keywords

ASA; Clopidogrel; Proton pump inhibitors; Upper gastrointestinal bleeding

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; PROTON PUMP INHIBITOR; TICLOPIDINE; TRIFLUSAL;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SPAIN; TRANSIENT ISCHEMIC ATTACK; UPPER GASTROINTESTINAL BLEEDING;

EID: 80054710080     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082011000700005     Document Type: Article

References (24)

1. Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002;347 (13):969-74.
2. Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Ann Intern Med 2005;143(4):241-50.
3. Sorensen R, Hansen ML, Abildstrom SZ, Hvelplund A, Andersson C, Jorgensen C, et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet 2009;374(9706):1967-74.
4. Lanas A, Perez-Aisa MA, Feu F, Ponce J, Saperas E, Santolaria S, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005;100 (8):1685-93.
5. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114(7):e257-354.
6. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002;23(23):1809-40.
7. van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24(1):28-66.
8. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Arch Mal Coeur Vaiss 2004;97(10):1019-30.
9. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005;353 (22):2373-83.
10. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. ESH/ESC 2007 Guidelines for the management of arterial hypertension. Rev Esp Cardiol 2007;60(9):968 e1-94.
11. Marin R, de la Sierra A, Armario P, Campo C, Banegas JR, Gorostidi M. 2005 Spanish guidelines in diagnosis and treatment of arterial hypertension. Med Clin (Barc) 2005;125(1):24-34.
12. Valdes S, Rojo-Martinez G, Soriguer F. Evolution of prevalence of type 2 diabetes in adult Spanish population. Med Clin (Barc) 2007;129 (9):352-5.
13. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348(9038):1329-39.
14. Lai KC, Chu KM, Hui WM, Wong BC, Hung WK, Loo CK, et al. Eso-meprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol 2006;4(7):860-5.
15. Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol;105(12):2533-49.
16. Fihn SD, McDonell M, Martin D, Henikoff J, Vermes D, Kent D, et al. Risk factors for complications of chronic anticoagulation. A multi-center study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med 1993;118(7):511-20.
17. Lanas A, Garcia-Rodriguez LA, Arroyo MT, Bujanda L, Gomollon F, Forne M, et al. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol 2007;102 (3):507-15.
18. Lanas A, Bajador E, Serrano P, Fuentes J, Carreno S, Guardia J, et al. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 2000;343(12):834-9.
19. Lai KC, Lam SK, Chu KM, Wong BC, Hui WM, Hu WH, et al. Lan-soprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002;346(26):2033-8.
20. Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009;180(7):713-8.
21. O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet 2009;374(9694):989-97.
22. Wyles H, Rehman HU. Inappropriate polypharmacy in the elderly. Eur J Intern Med 2005;16(5):311-3.
23. Jurado Hernandez AM, de Teresa Galvan J, Ruiz-Cabello Jimenez M, Pinel Julian LM. Evolution in the epidemiology of non-variceal upper digestive hemorrhage from 1985 to 2006. Rev Esp Enferm Dig 2008; 100(5):273-7.
24. Garrido A, Marquez JL, Guerrero FJ, Leo E, Pizarro MA, Trigo C. Changes in the etiology, outcome, and characteristics of patients with acute gastrointestinal bleeding between 1999 and 2005. Rev Esp Enferm Dig 2007;99(5):275-9.